TGFβ receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis

Brain

Volumn 129, Issue 9, 2006, Pages 2404-2415

  Malipiero, Ursula ^a   Koedel, Uwe ^d   Pfister, Hans Walter ^d   Levéen, Per ^e   Bürki, Kurt ^b   Reith, Walter ^c   Fontana, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Blood brain barrier; Chemokines; Innate immunity; Neuronal injury; Stroke

Indexed keywords

CEFTRIAXONE; CHEMOKINE; L SELECTIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BRAIN VASCULITIS; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DELETION; INNATE IMMUNITY; LEUKOCYTE; MOUSE; NECROTIZING ARTERITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BIOSYNTHESIS; BRAIN HEMORRHAGE; DISEASE MODEL; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MICROGLIA; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PHAGOCYTE; PHYSIOLOGY;

ANIMALS; CEREBRAL HEMORRHAGE; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; GENE DELETION; IMMUNITY, NATURAL; L-SELECTIN; MACROPHAGES; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, KNOCKOUT; MICROGLIA; NEUTROPHILS; PHAGOCYTES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 33749266512     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl192     Document Type: Article

References (53)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
2. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 1990; 171: 231-47.
3. Angstwurm K, Weber JR, Segert A, Burger W, Weih M, Freyer D, et al. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats. Neurosci Lett 1995; 191: 1-4.
4. Arbones ML, Ord DC, Ley K, Ratech H, Maynard-Curry C, Otten G, et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994; 1: 247-60.
5. Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300: 1524-5.
6. Brandt CT, Lundgren JD, Frimodt-Moller N, Christensen T, Benfield T, Espersen F, et al. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis. J Neuroimmunol 2005; 166: 126-31.
7. Chiavolini D, Tripodi S, Parigi R, Oggioni MR, Blasi E, Cintorino M, et al. Method for inducing experimental pneumococcal meningitis in outbred mice. BMC Microbiol 2004; 4: 36.
8. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-77.
9. Cui X, Zeni F, Vodovitz Y, Correa-de-Araujo R, Quezado M, Roberts A, et al. TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats. Cytokine 2003; 24: 115-27.
10. Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, et al. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun 1999; 67: 2590-601.
11. Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, Davidson JM, Nanney LB, et al. Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med 1991; 173: 1121-32.
12. Flanders KC, Ludecke G, Engels S, Cissel DS, Roberts AB, Kondaiah P, et al. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development 1991; 113: 183-91.
13. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 1987; 17: 1271-8.
14. Gerber J, Raivich G, Wellmer A, Noeske C, Kunst T, Werner A, et al. A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol (Berl) 2001; 101: 499-508.
15. Giampaolo C, Scheld M, Boyd J, Savory J, Sande M, Wills M. Leukocyte and bacterial interrelationships in experimental meningitis. Ann Neurol 1981; 9: 328-33.
16. Granert C, Raud J, Xie X, Lindquist L, Lindbom L. Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. J Clin Invest 1994; 93: 929-36.
17. Gresham HD, Ray CJ, O'Sullivan FX. Defective neutrophil function in the autoimmune mouse strain MRL/lpr. Potential role of transforming growth factor-beta. J Immunol 1991; 146: 3911-21.
18. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications, prognostic factors in a series of 87 cases. Brain 2003; 126: 1015-25.
19. Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 2003; 4: 376-85.
20. Kim WK, Hwang SY, Oh ES, Piao HZ, Kim KW, Han IO. TGF-beta1 represses activation, resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol 2004; 172: 7015-23.
21. Koedel U, Bernatowicz A, Frei K, Fontana A, Pfister HW. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J Immunol 1996; 157: 5185-91.
22. Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002; 2: 721-36.
23. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-61.
24. Leveen P, Larsson J, Ehinger M, Cilio CM, Sundler M, Sjostrand LJ, et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002; 100: 560-8.
25. Lewinsohn DM, Bargatze RF, Butcher EC. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leucocytes. J Immunol 1987; 138: 4313-21.
26. Lowrance JH, O'Sullivan FX, Caver TE, Waegell W, Gresham HD. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J Exp Med 1994; 180: 1693-703.
27. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003; 100: 1966-71.
28. Massague J. TGFbeta signaling: receptors, transducers and Mad proteins. Cell 1996; 85: 947-50.
29. Meli DN, Christen S, Leib SL, Tauber MG. Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis 2002; 15: 253-7.
30. Nau R, Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25: 38-45.
31. Perrella MA, Hsieh CM, Lee WS, Shieh S, Tsai JC, Patterson C, et al. Arrest of endotoxin-induced hypotension by transforming growth factor beta1. Proc Natl Acad Sci USA 1996; 93: 2054-9.
32. Pfister HW, Frei K, Ottnad B, Koedel U, Tomasz A, Fontana A. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis. J Exp Med 1992; 176: 265-8.
33. Reibman J, Meixler S, Lee TC, Gold LI, Cronstein BN, Haines KA, et al. Transforming growth factor beta 1 a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci USA 1991; 88: 6805-9.
34. Scheld WM, Giampaolo C, Boyd J, Savory J, Wills MR, Sande MA. Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitis. J Lab Clin Med 1982; 100: 218-29.
35. Schmeck B, Huber S, Moog K, Zahlten J, Hocke AC, Opitz B, et al. Pneumococci induced TLR- and Rac1-dependent NF-{kappa}B-recruitment to the IL-8 promoter in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L730-7.
36. Schroder NW, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2lipopolysaccharide binding protein (LBP), and CD 14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003; 278: 15587-94.
37. Seebach J, Bartholdi D, Frei K, Spanaus KS, Ferrero E, Widmer U, et al. Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J Immunol 1995; 155: 4367-75.
38. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 1993; 151: 2150-8.
39. Szanto S, Gal I, Gonda A, Glant TT, Mikecz K. Expression of L-selectin, but not CD 44, is required for early neutrophil extravasation in antigen-induced arthritis. J Immunol 2004; 172: 6723-34.
40. Tauber MG, Borschberg U, Sande MA. Influence of granulocytes on brain edema, intracranial pressure and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis 1988; 157: 456-64.
41. Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 1995; 181: 2259-64.
42. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334: 260-2.
43. Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD. Reduction of inflammation, tissue damage and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leucocytes. J Exp Med 1989; 170: 959-69.
44. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol 1991; 21: 1635-9.
45. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 84: 5788-92.
46. Watson SR, Fennie C, Lasky LA. Neutrophil influx into an inflammatory site inhibited by a soluble homing receptor-IgG chimaera. Nature 1991; 349: 164-7.
47. Weber JR, Angstwurm K, Rosenkranz T, Lindauer U, Freyer D, Burger W, et al. Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis. J Cereb Blood Flow Metab 1997; 17: 1221-9.
48. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006; 5: 123-9.
49. Welch GR, Wong HL, Wahl SM. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J Immunol 1990; 144: 3444-8.
50. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999; 18: 1280-91.
51. Yang YC, Piek E, Zavadil J, Liang D, Xie D, Heyer J, et al. Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci USA 2003; 100: 10269-74.
52. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5.
53. Zwahlen A, Nydegger UE, Vaudaux P, Lambert PH, Waldvogel FA. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis 1982; 145: 635-46.